GP681

· Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for GP681, covering 2023-11-14 to 2025-03-14. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Relative Bioavailability of GP681 Formulations in Healthy Chinese Male Subjects [Phase 1]